[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Pages 40863-40864]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16190]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


The National Institutes of Health (NIH) Scientific Workshop on 
Violence & Related Health Outcomes in Sexual & Gender Minority 
Communities Open Session

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Institutes of Health (NIH) will hold the Phase IV 
open session for the NIH Scientific Workshop on Violence and Related 
Health Outcomes in Sexual and Gender Minority (SGM) Communities to 
enhance our understanding of violence against SGM individuals and 
identify opportunities in violence-related research. The primary 
objectives of NIH's Phase IV meeting are: (1) To allow the public to 
participate, and (2) to further refine research opportunities.

DATES: The NIH Scientific Workshop on Violence and Related Health 
Outcomes in Sexual and Gender Minority Communities Phase IV virtual 
meeting will be held on Thursday, August 26, 2021, from 12:00-4:00 p.m. 
Eastern Daylight Time (New York, GMT).

ADDRESSES: The meeting will be held virtually via WebEx.
    The preliminary agenda and registration are available at https://tinyurl.com/SGMwkshp.

FOR FURTHER INFORMATION CONTACT: Irene Avila, Ph.D., Assistant 
Director, Sexual & Gender Minority Research Office (SGMRO), 
<a href="/cdn-cgi/l/email-protection#5c3d2a35303d351c313d353072323534723b332a"><span class="__cf_email__" data-cfemail="fc9d8a95909d95bc919d9590d2929594d29b938a">[email protected]</span></a>, 301-594-9701.

SUPPLEMENTARY INFORMATION: 
    Background: ``Sexual and gender minority'' is an umbrella term that 
includes, but is not limited to, individuals who identify as lesbian, 
gay, bisexual, asexual, transgender, Two-Spirit, queer, and/or 
intersex. Individuals with same-sex or -gender attractions or behaviors 
and those with a difference in sex development are also included. These 
populations also encompass those who do not self-identify with one of 
these terms but whose sexual orientation, gender identity or 
expression, or reproductive development is characterized by non-binary 
constructs of sexual orientation, gender, and/or sex.
    In accordance with Section 404N of the 21st Century Cures Act (Pub. 
L. 114-255), the Director of NIH shall encourage research on SGM 
populations. The Sexual and Gender Minority Research Office (SGMRO) 
coordinates SGM-related research and activities by working directly 
with NIH Institutes, Centers, and Offices. The Office was officially 
established in September 2015 within the Division of Program 
Coordination, Planning, and Strategic Initiatives (DPCPSI) in the NIH 
Office of the Director and has the following operational goals: (1) 
Advance rigorous research on the health of SGM populations in both the 
extramural and intramural research communities; (2) expand SGM health 
research by fostering partnerships and collaborations with a strategic 
array of internal and external stakeholders; (3) foster a highly 
skilled and diverse workforce in SGM health research; and (4) encourage 
data collection related to SGM populations in research and the 
biomedical research workforce. The Scientific Workshop on Violence and 
Related Health Outcomes in Sexual and Gender Minority Communities 
represents an important step in pursuing these goals specifically in 
the field of violence research.

The NIH Scientific Workshop on Violence and Related Health Outcomes in 
Sexual and Gender Minority Communities Phase IV Public Meeting Details

    The NIH Scientific Workshop on Violence and Related Health Outcomes 
in Sexual and Gender Minority Communities invites stakeholders 
throughout the scientific research community, clinical practice 
communities, patient and family advocates, scientific or professional 
organizations, federal partners, internal NIH stakeholders, and other 
interested members of the public to participate and provide comments, 
questions, or feedback at the workshop. The goal of the meeting is to 
identify opportunities in violence-related research. Public input will 
serve as a valuable element in the development of the final proposed 
research opportunities.
    This notice serves as the announcement for the fourth and final 
phase of the Scientific Workshop on Violence and Related Health 
Outcomes in Sexual and Gender Minority Communities. Phase I was the 
Request for Information (RFI) https://www.federalregister.gov/documents/2020/11/25/2020-26094/request-for-information-on-research-opportunities-related-to-the-national-institutes-of-health published in 
November 2020. The summary of the comments received can be found on the 
https://dpcpsi.nih.gov/sgmro website. Phase II was a session on the 
state of the science for violence research affecting SGM communities (a 
recording will be

[[Page 40864]]

available after August 26, 2021). The meeting applied an ecological 
model focusing on family of origin abuse across the lifespan, 
victimization by peers and friends, romantic and sexual partner 
violence, and community violence. Phase III included working groups to 
identify and describe research opportunities to further understand the 
role of violence in the health of SGM individuals. The working groups 
were comprised of these five domains:

<bullet> Demographics and Epidemiology
<bullet> Risk Factors and Pathways
<bullet> Preventive Interventions
<bullet> Treatment-focused Interventions
<bullet> Ethics and Logistical Challenges

    Phase IV will involve moderated discussions with the presenters 
from the Phase III working groups to refine research opportunities 
needed to further our understanding of violence in SGM communities. 
Audience feedback, comments, and questions during this session will 
help further refine the proposed research opportunities.

    Dated: July 21, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-16190 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>